Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Share-based Compensation: 2018-2025

Historic Share-based Compensation for Neurogene (NGNE) over the last 5 years, with Sep 2025 value amounting to $3.4 million.

  • Neurogene's Share-based Compensation rose 36.01% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.3 million, marking a year-over-year increase of 115.06%. This contributed to the annual value of $8.3 million for FY2024, which is 486.74% up from last year.
  • Per Neurogene's latest filing, its Share-based Compensation stood at $3.4 million for Q3 2025, which was down 1.26% from $3.4 million recorded in Q2 2025.
  • Neurogene's 5-year Share-based Compensation high stood at $4.0 million for Q1 2025, and its period low was $293,000 during Q1 2023.
  • Over the past 3 years, Neurogene's median Share-based Compensation value was $2.5 million (recorded in 2024), while the average stood at $2.2 million.
  • Data for Neurogene's Share-based Compensation shows a peak YoY soared of 600.56% (in 2024) over the last 5 years.
  • Neurogene's Share-based Compensation (Quarterly) stood at $355,000 in 2023, then skyrocketed by 600.56% to $2.5 million in 2024, then surged by 36.01% to $3.4 million in 2025.
  • Its last three reported values are $3.4 million in Q3 2025, $3.4 million for Q2 2025, and $4.0 million during Q1 2025.